ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Kyowa Kirin Receives Partial Change Approval for ORKEDIA in Japan firstwordpharma
December 22, 2019The approval is based on the result of the Phase 3 clinical trial that evaluates the efficacy of ORKEDIA for hypercalcemia in patients with parathyroid carcinoma or primary hyperparathyroidism who are unable to undergo parathyroidectomy or relapse after p
Pharma Sources Insight January 2025
